| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.2M | -6.6% |
| SG&A Expense | $5.0M | +17.9% |
| Operating Income | -$8.2M | -6.8% |
| Net Income | -$8.2M | -4.4% |
| EPS (Basic) | -$1.28 | +44.3% |
| EPS (Diluted) | -$1.28 | +44.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.0M | -24.3% |
| Current Assets | $7.6M | -18.9% |
| Total Assets | $7.7M | -19.0% |
| Current Liabilities | $831K | +22.5% |
| Total Liabilities | $834K | +18.3% |
| Stockholders' Equity | $6.9M | -22.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.0M | +17.4% |
| Financing Cash Flow | $4.7M | -58.1% |